Provider Updates for November 2026
Healthfirst's Provider Updates for November 2026 contains reimbursement policy PO-RE-045v6, Biomarkers for Myocardial Infarction and Chronic Heart Failure, which the source lists with an effective date of November 1, 2026. The policy states that measuring quantitative cardiac troponin meets coverage criteria up to four times within the first 72 hours after initial presentation with signs and symptoms of acute coronary syndrome, while AST, CKMB, CK, LDH, myoglobin and ST2 analysis in the outpatient setting do not meet coverage criteria. The revision history says the June 3, 2026 review updated the background, guidelines and references and did not necessitate any modifications to coverage criteria.